Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer's disease.

Calvo-Rodriguez, Maria; Hou, Steven S; Snyder, Austin C; Kharitonova, Elizabeth K; Russ, Alyssa N; Das, Sudeshna; Fan, Zhanyun; Muzikansky, Alona et al. · Nat Commun · 2020

basic_science · Level V

Where this comes from

Abstract

Mitochondria contribute to shape intraneuronal Ca<sup>2+</sup> signals. Excessive Ca<sup>2+</sup> taken up by mitochondria could lead to cell death. Amyloid beta (Aβ) causes cytosolic Ca<sup>2+</sup> overload, but the effects of Aβ on mitochondrial Ca<sup>2+</sup> levels in Alzheimer's disease (AD) remain unclear. Using a ratiometric Ca<sup>2+</sup> indicator targeted to neuronal mitochondria and intravital multiphoton microscopy, we find increased mitochondrial Ca<sup>2+</sup> levels associated with plaque deposition and neuronal death in a transgenic mouse model of cerebral β-amyloidosis. Naturally secreted soluble Aβ applied onto the healthy brain increases Ca<sup>2+</sup> concentration in mitochondria, which is prevented by blockage of the mitochondrial calcium uniporter. RNA-sequencing from post-mortem AD human brains shows downregulation in the expression of mitochondrial influx Ca<sup>2+</sup> transporter genes, but upregulation in the genes related to mitochondrial Ca<sup>2+</sup> efflux pathways, suggesting a counteracting effect to avoid Ca<sup>2+</sup> overload. We propose lowering neuronal mitochondrial Ca<sup>2+</sup> by inhibiting the mitochondrial Ca<sup>2+</sup> uniporter as a novel potential therapeutic target against AD.

Medical subject headings